Join Life Sciences attorneys from BakerHostetler and Kinstellar on Wednesday, September 27, as we collaborate to highlight three hot topics trending in both the U.S. and European pharmaceutical sectors:
• Drug Shortages,
• Decentralized Clinical Trials and
• M&A Transaction Diligence.
We will shed light on the persistent issue of drug shortages and how U.S. and European regulators are planning to address them, discuss how decentralized clinical trials are revolutionizing the clinical research landscape for drug development, and offer insights into the growing importance of M&A transaction diligence for drug companies.
1.0 hour of CLE credit is pending for California, Colorado, Florida, Georgia, New York, Pennsylvania, Ohio and New Jersey (through reciprocity). CLE credit may be available in other states if requested.
SPEAKERS
Drug Shortages
Speakers
Winston Kirton, partner at BakerHostetler
wkirton@bakerlaw.com
Tomáš Čihula, partner at Kinstellar
tomas.cihula@kinstellar.com
Decentralized Clinical Trials
Speakers
Payal Cramer, counsel at BakerHostetler
Eszter Takácsi-Nagy, senior associate at Kinstellar
eszter.takacsi-nagy@kinstellar.com
M&A Transaction Diligence
Speakers
Winston Kirton, partner at BakerHostetler
wkirton@bakerlaw.com
Jan Juroška, partner at Kinstellar
jan.juroska@kinstellar.com
Contact Information
For more information contact Matthew Shannon at matthew.shannon@kinstellar.com or Krunali Shroff at kshroff@bakerlaw.com